HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Nishiyama Selected Research
M Nishiyama Research Topics
Disease
10
Neoplasms (Cancer)
10/2011 - 02/2000
2
Starvation
12/2001 - 08/2001
1
Breast Neoplasms (Breast Cancer)
01/2017
1
Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
10/2013
1
IGA Glomerulonephritis (IGA Nephropathy)
10/2013
1
Hyperphagia (Overeating)
04/2013
1
AIDS-Related Complex (ARC)
04/2013
1
Obesity
04/2013
1
Myocardial Infarction
10/2011
1
Atherosclerotic Plaque (Atheroma)
10/2011
1
Stroke (Strokes)
10/2011
1
Atherosclerosis
10/2011
1
Varicose Veins (Varicose Vein)
11/2010
1
Pneumonia (Pneumonitis)
09/2010
1
Infections
09/2010
1
Human Influenza (Influenza)
09/2010
1
Hypoxia (Hypoxemia)
07/2008
1
Pituitary Neoplasms (Pituitary Adenoma)
02/2006
1
Malnutrition (Nutritional Deficiencies)
02/2006
1
Hydronephrosis
10/2001
1
Peritoneal Diseases
10/2001
1
Carcinoma (Carcinomatosis)
10/2001
1
Ulcer
05/2001
1
Hypersensitivity (Allergy)
02/2001
1
Gastroparesis
02/2001
1
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
09/2000
1
Residual Neoplasm
08/2000
1
Colorectal Neoplasms (Colorectal Cancer)
08/2000
1
Malaria
07/2000
1
Stomach Neoplasms (Stomach Cancer)
06/2000
1
Dementia (Dementias)
05/2000
1
Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
05/2000
1
Alzheimer Disease (Alzheimer's Disease)
05/2000
1
Colonic Neoplasms (Colon Cancer)
04/2000
1
Tetanus
03/2000
1
Tuberculosis (Tuberculoses)
03/2000
1
Glioblastoma (Glioblastoma Multiforme)
02/2000
Drug/Important Bio-Agent (IBA)
5
Messenger RNA (mRNA)
IBA
04/2013 - 08/2000
2
ErbB Receptors (EGF Receptor)
IBA
01/2017 - 08/2000
2
Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)
IBA
04/2013 - 08/2001
2
Corticosterone
IBA
02/2006 - 08/2001
2
Neuropeptides
IBA
12/2001 - 08/2001
1
Glutamic Acid (Glutamate)
FDA Link
10/2013
1
Acids
IBA
10/2013
1
Ligands
IBA
04/2013
1
Aurothioglucose (Gold 50)
IBA
04/2013
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
10/2011
1
Lipids
IBA
11/2010
1
Antiviral Agents (Antivirals)
IBA
09/2010
1
Antigens
IBA
09/2010
1
Oxygen (Dioxygen)
IBA
09/2010
1
Histones (Histone)
IBA
07/2008
1
Proteins (Proteins, Gene)
FDA Link
07/2008
1
Transcription Factors (Transcription Factor)
IBA
07/2008
1
parthenolide
IBA
02/2006
1
Survivin
IBA
02/2006
1
Antioxidants
IBA
02/2006
1
Dehydroepiandrosterone (DHEA)
IBA
02/2006
1
NF-kappa B (NF-kB)
IBA
02/2006
1
Neuropeptide Y
IBA
12/2001
1
Hormones (Hormone)
IBA
12/2001
1
Adrenocorticotropic Hormone (ACTH)
FDA Link
12/2001
1
Pro-Opiomelanocortin (Proopiomelanocortin)
IBA
12/2001
1
6- ((2- (dimethylamino)ethyl)amino)- 3- hydroxy- 7H- indeno(2,1- c)quinolin- 7- one
IBA
11/2001
1
Tegafur
IBA
10/2001
1
titanium silicide (TS-1)
IBA
10/2001
1
Histone Deacetylases (Histone Deacetylase)
IBA
08/2001
1
Glucocorticoids
IBA
08/2001
1
Mineralocorticoid Receptors (Mineralocorticoid Receptor)
IBA
08/2001
1
Glucocorticoid Receptors (Glucocorticoid Receptor)
IBA
08/2001
1
Histone Deacetylase Inhibitors
IBA
08/2001
1
Appetite Depressants (Anorectics)
IBA
08/2001
1
HLA-B51 Antigen
IBA
05/2001
1
CRF receptor type 2
IBA
02/2001
1
IgE Receptors (Fc epsilon RI)
IBA
02/2001
1
Inosine Triphosphate (ITP)
IBA
09/2000
1
Transforming Growth Factor alpha (TGF-alpha)
IBA
08/2000
1
KI 7
IBA
08/2000
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
08/2000
1
Apolipoproteins E (ApoE)
IBA
05/2000
1
Apolipoproteins
IBA
05/2000
1
Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)
IBA
05/2000
1
Tetanus Toxoid (Vaccine, Tetanus)
FDA Link
03/2000
1
trioctyl phosphine oxide (TOPO)
IBA
02/2000
1
Type I DNA Topoisomerases (Topoisomerase I)
IBA
02/2000
1
Enzymes
IBA
02/2000
1
NADP (NADPH)
IBA
02/2000
1
Nimustine
IBA
02/2000
1
Tubulin
IBA
02/2000
1
Oxidoreductases (Dehydrogenase)
IBA
02/2000
1
quinone (benzoquinone)
IBA
02/2000
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
09/2001 - 02/2000
3
Therapeutics
06/2000 - 03/2000
1
Secondary Prevention
10/2011
1
Electrocoagulation (Electrocautery)
08/2000
1
Mosquito Nets
07/2000